BlackRock, Inc. Reports 5.7% Ownership in Semler Scientific, Inc.

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5.7% ownership in Semler Scientific, Inc. as of September 30, 2025. The filing indicates that BlackRock beneficially owns 858,705 shares of Semler Scientific's common stock, with 839,794 shares held with sole voting power and 858,705 shares with sole dispositive power. The filing also notes that various persons have the right to receive dividends or proceeds from the sale of the common stock, but no single person's interest exceeds 5% of the total outstanding shares. The filing was signed by Spencer Fleming, Managing Director of BlackRock, Inc., on October 17, 2025. This filing is in accordance with SEC Release No. 34-39538, which requires the disaggregation of securities beneficially owned by different business units of BlackRock.